<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    8748261
   </pmid>
   <datecreated>
    <year>
     1996
    </year>
    <month>
     10
    </month>
    <day>
     11
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1996
    </year>
    <month>
     10
    </month>
    <day>
     11
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0095-1137
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       34
      </volume>
      <issue>
       1
      </issue>
      <pubdate>
       <year>
        1996
       </year>
       <month>
        Jan
       </month>
      </pubdate>
     </journalissue>
     <title>
      Journal of clinical microbiology
     </title>
     <isoabbreviation>
      J. Clin. Microbiol.
     </isoabbreviation>
    </journal>
    <articletitle>
     Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.
    </articletitle>
    <pagination>
     <medlinepgn>
      1-9
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      We investigated the appearance and evolution of immunoglobulin M (IgM) and IgG antibodies to Borrelia burgdorferi in 46 patients with culture-proven erythema migrans (EM). All patients received antimicrobial treatment and were prospectively evaluated for up to 1 year. A total of 257 serially collected serum samples were tested by commercial IgG-IgM enzyme-linked immunosorbent assay and separate IgM and IgG immunoblots (IBs). At the baseline, 33% of the patients had a positive ELISA result and 43% of the patients had a positive IgM IB result by using the criteria of the Centers for Disease Control and Prevention-Association of State and Territorial Public Health Laboratory Directors for the interpretation of IB results. Positive serology at the baseline and the rate of seroconversion correlated directly with disease duration and/or evidence of dissemination prior to treatment. At days 8 to 14 after the baseline, 91% of patients had a positive ELISA result and/or IgM IB result. Peak IgM antibody levels were seen at this time in patients with localized or disseminated disease. The most frequent IgM bands at the baseline and the peak were of 24 kDa (OspC), 41 kDa, and 37 kDa. Although 89% of the patients developed IgG antibodies as determined at a follow-up examination, only 22% were positive by the IgG IB criteria of the Centers for Disease Control and Prevention-Association of State and Territorial Public Health Laboratory Directors. The persistence of antibodies was directly related to disease duration and/or dissemination prior to treatment. Since IgM antibodies to the 24- and 41-kDa antigens remained detectable for long periods, 38% of IgM IBs were still positive at 1 year postbaseline. IgM to antigens of 39, 58, 60, 66, or 93 kDa, conversely, were most often seen in sera obtained within 1 month postbaseline. Their presence may be of assistance in confirming a recent infection with B. burgdorferi in individuals living in areas where Lyme disease is endemic.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Pathology, New York Medical College, Valhalla, USA.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Aguero-Rosenfeld
      </lastname>
      <forename>
       M E
      </forename>
      <initials>
       ME
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Nowakowski
      </lastname>
      <forename>
       J
      </forename>
      <initials>
       J
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Bittker
      </lastname>
      <forename>
       S
      </forename>
      <initials>
       S
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Cooper
      </lastname>
      <forename>
       D
      </forename>
      <initials>
       D
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Nadelman
      </lastname>
      <forename>
       R B
      </forename>
      <initials>
       RB
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Wormser
      </lastname>
      <forename>
       G P
      </forename>
      <initials>
       GP
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <grantlist completeyn="Y">
     <grant>
      <grantid>
       R01-AR41508
      </grantid>
      <acronym>
       AR
      </acronym>
      <agency>
       NIAMS NIH HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
     <grant>
      <grantid>
       R01-AR43135
      </grantid>
      <acronym>
       AR
      </acronym>
      <agency>
       NIAMS NIH HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
     <grant>
      <grantid>
       U50/CCU 210280-01
      </grantid>
      <agency>
       PHS HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
    </grantlist>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, P.H.S.
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     UNITED STATES
    </country>
    <medlineta>
     J Clin Microbiol
    </medlineta>
    <nlmuniqueid>
     7505564
    </nlmuniqueid>
    <issnlinking>
     0095-1137
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Antibodies, Bacterial
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Antigens, Bacterial
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Immunoglobulin G
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Immunoglobulin M
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1988 Dec 1;319(22):1441-6
     </refsource>
     <pmid version="1">
      3054554
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 1989 Dec 22-29;262(24):3464-5
     </refsource>
     <pmid version="1">
      2685385
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Infect Immun. 1986 May;52(2):549-54
     </refsource>
     <pmid version="1">
      3516878
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Invest. 1986 Oct;78(4):934-9
     </refsource>
     <pmid version="1">
      3531237
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 1987 Nov;156(5):852-3
     </refsource>
     <pmid version="1">
      3655406
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 1987 Apr;155(4):756-65
     </refsource>
     <pmid version="1">
      3819479
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Med. 1985 Feb;78(2):235-40
     </refsource>
     <pmid version="1">
      3970049
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Infect Immun. 1983 Aug;41(2):795-804
     </refsource>
     <pmid version="1">
      6192088
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 1983 Mar 31;308(13):733-40
     </refsource>
     <pmid version="1">
      6828118
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Infect Immun. 1993 Feb;61(2):423-31
     </refsource>
     <pmid version="1">
      7678585
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1995 Jan;33(1):103-9
     </refsource>
     <pmid version="1">
      7699024
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1995 Feb;33(2):419-27
     </refsource>
     <pmid version="1">
      7714202
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1994 Jul;32(7):1733-8
     </refsource>
     <pmid version="1">
      7929767
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1994 Aug;32(8):1958-62
     </refsource>
     <pmid version="1">
      7989549
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1994 Jun;32(6):1519-25
     </refsource>
     <pmid version="1">
      8077398
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Infect Immun. 1993 Dec;61(12):5097-105
     </refsource>
     <pmid version="1">
      8225587
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1993 Dec;31(12):3090-5
     </refsource>
     <pmid version="1">
      8308100
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1993 Dec;31(12):3096-108
     </refsource>
     <pmid version="1">
      8308101
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 1993 Feb;167(2):392-400
     </refsource>
     <pmid version="1">
      8380611
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Infect Immun. 1993 May;61(5):2182-91
     </refsource>
     <pmid version="1">
      8478108
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Med. 1992 Apr;92(4):396-403
     </refsource>
     <pmid version="1">
      1313637
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Exp Med. 1992 Sep 1;176(3):799-809
     </refsource>
     <pmid version="1">
      1339462
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 1992 Apr;165(4):658-66
     </refsource>
     <pmid version="1">
      1372635
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Infect Immun. 1992 Oct;60(10):4309-21
     </refsource>
     <pmid version="1">
      1398941
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Infect Dis. 1992 Nov;15(5):788-93
     </refsource>
     <pmid version="1">
      1445977
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1992 Feb;30(2):370-6
     </refsource>
     <pmid version="1">
      1537905
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Mol Microbiol. 1992 Feb;6(4):503-9
     </refsource>
     <pmid version="1">
      1560779
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Rheumatol. 1992 Apr;19(4):582-7
     </refsource>
     <pmid version="1">
      1593581
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):224-32
     </refsource>
     <pmid version="1">
      1597198
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Scand J Infect Dis Suppl. 1991;77:94-101
     </refsource>
     <pmid version="1">
      1947819
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1991 Jan;29(1):174-82
     </refsource>
     <pmid version="1">
      1993754
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Immunol. 1991 Apr 15;146(8):2776-82
     </refsource>
     <pmid version="1">
      2016526
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 1990 Jun;28(6):1329-37
     </refsource>
     <pmid version="1">
      2380361
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Zentralbl Bakteriol Mikrobiol Hyg A. 1986 Dec;263(1-2):92-102
     </refsource>
     <pmid version="1">
      2437739
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):871-7
     </refsource>
     <pmid version="1">
      2512131
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 1988 Apr;157(4):790-7
     </refsource>
     <pmid version="1">
      3279140
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Antibodies, Bacterial
     </descriptorname>
     <qualifiername majortopicyn="Y">
      blood
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Antigens, Bacterial
     </descriptorname>
     <qualifiername majortopicyn="N">
      chemistry
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Borrelia burgdorferi Group
     </descriptorname>
     <qualifiername majortopicyn="Y">
      immunology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Enzyme-Linked Immunosorbent Assay
     </descriptorname>
     <qualifiername majortopicyn="N">
      statistics &amp; numerical data
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Erythema Chronicum Migrans
     </descriptorname>
     <qualifiername majortopicyn="N">
      diagnosis
     </qualifiername>
     <qualifiername majortopicyn="Y">
      immunology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Immunoblotting
     </descriptorname>
     <qualifiername majortopicyn="N">
      statistics &amp; numerical data
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Immunoglobulin G
     </descriptorname>
     <qualifiername majortopicyn="N">
      blood
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Immunoglobulin M
     </descriptorname>
     <qualifiername majortopicyn="N">
      blood
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Molecular Weight
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Sensitivity and Specificity
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Time Factors
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC228718
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1996
     </year>
     <month>
      1
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1996
     </year>
     <month>
      1
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1996
     </year>
     <month>
      1
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     8748261
    </articleid>
    <articleid idtype="pmc">
     PMC228718
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

